15.44 USD
↗ 1.27 (8.96%)AT CLOSE (11:59 AM EDT)
Biohaven Ltd.
BHVNNYSE • USD
15.39
↘ 0.05 (0.32%)
POST MARKET (AS OF 06:17 PM EDT)
Post Market
AS OF 06:17 PM EDT
15.39
↘ 0.05 (0.32%)
Market: OPEN
Biohaven Ltd. (BHVN) trades at $14.84 per share. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jul 17, 2026.
Open?$13.74
High?$15.51
Low?$13.62
Prev. Close?$14.17
Volume?3.5M
Avg. Volume?3.5M
VWAP?$15.16
Rel. Volume?1.00x
Bid / Ask
Bid?$14.91 × 100
Ask?$15.88 × 1.0K
Spread?$0.97
Midpoint?$15.40
Valuation & Ratios
Market Cap?2.1B
Shares Out?150.6M
Float?119.4M
Float %?79.3%
P/E Ratio?N/A
P/B Ratio?16.47
EPS?-$4.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Themes
Employees
274
Market Cap
2.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2022-09-23
Address
215 CHURCH STREET
NEW HAVEN, CT 06510
Phone: 203-404-0410
NEW HAVEN, CT 06510
Phone: 203-404-0410
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?41
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.62Distress
Confidence?50%Low
Short InterestHigh
Short % of Float?17.15%High
Short Interest?20.5M
Days to Cover?4.2
Free Float119.4M
Avg Daily Volume4.9M
Settlement Date2026-06-30
Financial Health
Current Ratio?7.41Strong
Quick Ratio?7.41Strong
Cash Ratio?5.24Strong
Debt/Equity?1.87High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?16.47HIGH▾
Peers100
S&P10
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-500.1%WEAK▾
S&P3
ROA?-138.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-594486000
Enterprise Value?$2.1B
Fundamentals ratios updated end of day